Intermittent or sustained systemic inflammation and the preterm brain

Pediatric Research

Volumn 75, Issue 3, 2014, Pages 376-380

  Dammann, Olaf ^a,b,c   Leviton, Alan ^d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; HISTONE DEACETYLASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA; PROTEIN S100B; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; ASSISTED VENTILATION; ASTROCYTE; AUTISM; AUTOPHAGY; BRAIN DAMAGE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CEREBRAL PALSY; CHROMATIN; CYTOKINE PRODUCTION; DEVELOPMENTAL DISORDER; DNA METHYLATION; ENDOPLASMIC RETICULUM STRESS; EPIGENETICS; FETUS RISK; HALF LIFE TIME; HEAD INJURY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INTERMITTENT OR SUSTAINED SYSTEMIC INFLAMMATION; LEUKOCYTOSIS; LUNG BAROTRAUMA; MACROGLIA; MACROPHAGE; MICROCEPHALY; MICROGLIA; MONOCYTE; NONHUMAN; PERINATAL INFECTION; POSITIVE FEEDBACK; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; SYSTEMIC DISEASE; TRACHEAL ASPIRATION PROCEDURE; UNFOLDED PROTEIN RESPONSE;

BRAIN DISEASES; EPIGENESIS, GENETIC; HUMANS; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84896840077     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.238     Document Type: Article

References (69)

1. Leviton A, Gilles FH. An epidemiologic study of perinatal telencephalic leucoencephalopathy in an autopsy population. J Neurol Sci 1973;18:53-66.
2. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol 1993;35:553-8.
3. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8.
4. Dammann O. Persistent neuro-inflammation in cerebral palsy: a therapeutic window of opportunity? Acta Paediatr 2007;96:6-7.
5. Kulik DM, Uleryk EM, Maguire JL. Does this child have appendicitis? A systematic review of clinical prediction rules for children with acute abdominal pain. J Clin Epidemiol 2013;66:95-104.
6. Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth 2010;2:161-75.
7. McCall CE, El Gazzar M, Liu T, Vachharajani V, Yoza B. Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J Leukoc Biol 2011;90:439-46.
8. Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 2013;339:166-72.
9. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012;72:1491-501.
10. Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injury-an inflammatory disease? Brain Res Brain Res Rev 2005;48:388-99.
11. Thornton C, Rousset CI, Kichev A, et al. Molecular mechanisms of neonatal brain injury. Neurol Res Int 2012;2012:506320.
12. Anthony DC, Couch Y, Losey P, Evans MC. The systemic response to brain injury and disease. Brain Behav Immun 2012;26:534-40.
13. d'Avila JC, Lam TI, Bingham D, et al. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J Neuroinflammation 2012;9:31.
14. Fleiss B, Gressens P. Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol 2012;11:556-66.
15. Lin CY, Chang YC, Wang ST, Lee TY, Lin CF, Huang CC. Altered inflammatory responses in preterm children with cerebral palsy. Ann Neurol 2010;68:204-12.
16. Suvisaari J, Mantere O. Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets 2013;13:59-70.
17. Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 2011;69(5 Pt 2):26R-33R.
18. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999;45(4 Pt 1):500-9.
19. Rousset CI, Chalon S, Cantagrel S, et al. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr Res 2006;59:428-33.
20. Winerdal M, Winerdal ME, Kinn J, Urmaliya V, Winqvist O, Adén U. Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice. PLoS One 2012;7:e36422.
21. th post-menstrual week. Early Hum Dev 2011;87:325-30.
22. Park ES, Park CI, Choi KS, Choi IH, Shin JS. Over-expression of S100B protein in children with cerebral palsy or delayed development. Brain Dev 2004;26:190-6.
23. O'Shea TM, Allred EN, Kuban KC, et al.; Extremely Low Gestational Age Newborn (ELGAN) Study Investigators. Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. J Pediatr 2012;160:395-401.e4.
24. Leviton A, Fichorova R, Yamamoto Y, et al. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine 2011;53:66-73.
25. Leviton A, Dammann O, Durum SK. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol 2005;58:821-8.
26. Bose CL, Laughon MM, Allred EN, et al.; ELGAN Study Investigators. Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine 2013;61:315-22.
27. Capoluongo E, Vento G, Santonocito C, et al. Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequency oscillatory ventilation or synchronized intermittent mandatory ventilation. Eur Cytokine Netw 2005;16:199-205.
28. Nathe KE, Mancuso CJ, Parad R, et al. Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation. Pediatr Res 2012;72:203-11.
29. Sood BG, Shankaran S, Schelonka RL, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokine profiles of preterm neonates with fungal and bacterial sepsis. Pediatr Res 2012;72:212-20.
30. Leviton A, O'Shea TM, Bednarek FJ, Allred EN, Fichorova RN, Dammann O; ELGAN Study Investigators. Systemic responses of preterm newborns with presumed or documented bacteraemia. Acta Paediatr 2012;101:355-9.
31. Cuenca AG, Wynn JL, Moldawer LL, Levy O. Role of innate immunity in neonatal infection. Am J Perinatol 2013;30:105-12.
32. Sherman MP. New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol 2010;37:565-79.
33. Lucas K, Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 Pathway. Mol Neurobiol 2013;48:190-204.
34. Ariel A, Timor O. Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis. J Pathol 2013;229:250-63.
35. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
36. Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012;67:1193-202.
37. Jones CA, Cayabyab RG, Kwong KY, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-75.
38. Blahnik MJ, Ramanathan R, Riley CR, Minoo P. Lipopolysaccharide induced tumor necrosis factor-alpha and IL-10 production by lung macrophages from preterm and term neonates. Pediatr Res 2001;50:726-31.
39. Kotecha S, Mildner RJ, Prince LR, et al. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 2003;58:961-7.
40. Nguyen CN, Schnulle PM, Chegini N, Luo X, Koenig JM. Neonatal neutrophils with prolonged survival secrete mediators associated with chronic inflammation. Neonatology 2010;98:341-7.
41. Hanna N, Vasquez P, Pham P, et al. Mechanisms underlying reduced apoptosis in neonatal neutrophils. Pediatr Res 2005;57:56-62.
42. Vedder H, Schreiber W, Yassouridis A, Gudewill S, Galanos C, Pollmächer T. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm Res 1999;48:67-74.
43. Dammann O, Phillips TM, Allred EN, et al.; ELGAN STUDY INVESTIGATORS. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001;13:234-9.
44. Skogstrand K, Hougaard DM, Schendel DE, Bent NP, Svaerke C, Thorsen P. Association of preterm birth with sustained postnatal inflammatory response. Obstet Gynecol 2008;111:1118-28.
45. Brochu ME, Girard S, Lavoie K, Sébire G. Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study. J Neuroinflammation 2011;8:55.
46. Gille C, Dreschers S, Leiber A, et al. The CD95/CD95L pathway is involved in phagocytosis-induced cell death of monocytes and may account for sustained inflammation in neonates. Pediatr Res 2013;73(4 Pt 1):402-8.
47. Wynn JL, Levy O. Role of innate host defenses in susceptibility to earlyonset neonatal sepsis. Clin Perinatol 2010;37:307-37.
48. Thornton NL, Cody MJ, Yost CC. Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology 2012;101:140-6.
49. Raymond T, Schaller M, Hogaboam CM, Lukacs NW, Rochford R, Kunkel SL. Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation. Proc Am Thorac Soc 2007;4:635-41.
50. Zhao J, Yang X, Auh SL, Kim KD, Tang H, Fu YX. Do adaptive immune cells suppress or activate innate immunity? Trends Immunol 2009;30:8-12.
51. Wehrens EJ, Prakken BJ, van Wijk F. T cells out of control-impaired immune regulation in the inflamed joint. Nat Rev Rheumatol 2013;9:34-42.
52. Foster SL, Medzhitov R. Gene-specific control of the TLR-induced inflammatory response. Clin Immunol 2009;130:7-15.
53. Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J Immunol 1998;160:3729-36.
54. Aung HT, Schroder K, Himes SR, et al. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J 2006;20:1315-27.
55. Zhu H, Shan L, Schiller PW, Mai A, Peng T. Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation. J Biol Chem 2010;285:9429-36.
56. Natoli G. Tuning up inflammation: how DNA sequence and chromatin organization control the induction of inflammatory genes by NF-kappaB. FEBS Lett 2006;580:2843-9.
57. Mullican SE, Gaddis CA, Alenghat T, et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev 2011;25:2480-8.
58. Chen X, Barozzi I, Termanini A, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci U S A 2012;109: E2865-74.
59. Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 2011;32:335-43.
60. Boldin MP, Baltimore D. MicroRNAs, new effectors and regulators of NF-κB. Immunol Rev 2012;246:205-20.
61. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013;38:209-23.
62. Pittman K, Kubes P. Damage-associated molecular patterns control neutrophil recruitment. J Innate Immun 2013;5:315-23.
63. Bueter W, Dammann O, Leviton A. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res 2009;66:487-94.
64. Voigt A, Rahnefeld A, Kloetzel PM, Krüger E. Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle. Front Physiol 2013;4:42.
65. Palazzo E, Rossi F, de Novellis V, Maione S. Endogenous modulators of TRP channels. Curr Top Med Chem 2013;13:398-407.
66. Bendix I, Schulze C, Haefen Cv, et al. Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity. Int J Mol Sci 2012;13:12939-51.
67. Barone F, Nayar S, Buckley CD. The role of non-hematopoietic stromal cells in the persistence of inflammation. Front Immunol 2012;3:416.
68. Wolfberg AJ, Dammann O, Gressens P. Anti-inflammatory and immunomodulatory strategies to protect the perinatal brain. Semin Fetal Neonatal Med 2007;12:296-302.
69. Degos V, Loron G, Mantz J, Gressens P. Neuroprotective strategies for the neonatal brain. Anesth Analg 2008;106:1670-80.